Quality Sustainability in Pharma: Where Culture Becomes the True Competitive Edge
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.
Discover how pharma leaders can build quality sustainability through resilient systems, adaptive culture and a culture of continuous improvement.

AstraZeneca takes a 12% stake in Summit Therapeutics for $2 billion to co-develop ivonescimab, a PD-1/VEGF bispecific antibody.

Indirect analysis of ACHIEVE-3 and PIONEER PLUS data positions Lilly's Foundayo ahead of oral semaglutide on weight loss, with manufacturing scalability implications for both molecules.

Novo Nordisk licenses Hengrui's oral GLP-1 candidate for up to $2.6B, signalling a manufacturing pivot toward solid-dose in the weight-loss drug space.

FDA and CRCG host a two-day LAI generics workshop in December 2026, targeting IVRT, bioequivalence, and ANDA deficiency patterns for complex injectables.
Latest edition
Podcast
SPONSORED
SPONSORED
SPONSORED
Oct 06
Oct 20From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
